Home > News > Anti-cancer nanotechnology - a two-pronged attack
August 1st, 2005
Anti-cancer nanotechnology - a two-pronged attack
Richard Jones: Drug delivery - and in particular the delivery of anti-cancer therapeutics - has emerged as one of the major applications of nanotechnology in medicine. There’s a nice brief review of the subject by Ruth Duncan in this month’s issue of Nano Today: - Nanomedicine gets clinical . An interesting paper in this week’s Nature reports a significant new development from Sasisekharan’s group at MIT, in which two drugs are combined in a single delivery system. This nanovector first selectively targets tumour tissue, then releases a drug which cuts off the blood supply to the tumour, isolating and starving it, and then releases a second drug which directly attacks the tumour cells.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014
PAM-XIAMEN Offers UV LED wafer April 15th, 2014
Nanocrystalline cellulose modified into an efficient viral inhibitor April 15th, 2014